|
|
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.United States |
First Approval Date02 Oct 2012 |
|
|
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.United States |
First Approval Date27 Sep 2002 |
|
Mechanism5-HT1B receptor agonists [+1] |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.Japan |
First Approval Date11 Apr 2002 |
100 Clinical Results associated with Viatris Pharmaceutical Co. Ltd.
0 Patents (Medical) associated with Viatris Pharmaceutical Co. Ltd.
100 Deals associated with Viatris Pharmaceutical Co. Ltd.
100 Translational Medicine associated with Viatris Pharmaceutical Co. Ltd.